Updates to the Australian Pharmaceutical Benefits Scheme
22 May 2023
Update
Services Australia has published a release detailing new and amended listings of medications on the Australian Pharmaceutical Benefits Scheme (PBS), effective from 1 May 2023.
Amendments have been made to a range of medications on the PBS, including the following medications:
- Methylphenidate (Ritalin® LA) being amended to allow access for adults with a retrospective diagnosis of ADHD. This includes access to capsules containing methylphenidate hydrochloride 10 mg, 20 mg, 30 mg, 40 mg, 60mg (modified release).
- Naltrexone (Naltrexone GH®) having a reduction in authority level for the treatment of alcohol dependence.
Enquiries regarding new and amended listings can be directed to the PBS at pbs@health.gov.au.
More news & views
20 May 2025
The updated RANZCP Supervisor Handbook is now available
The updated RANZCP Supervisor Handbook is now available with new updates to help you excel in your r...
14 May 2025
Discrimination, bullying and harassment
The RANZCP has an established Discrimination Bullying and Harassment Policy (DBH Policy) which sets ...
04 May 2025
Psychiatrists welcome returned Albanese Government, urge action on workforce commitments
Psychiatrists are calling on the incoming Albanese Government to act swiftly on its promise to grow ...